Back to Results
First PageMeta Content
Pharmacology / Biomarkers / Biotechnology / Chemical pathology / Osteopontin / Food and Drug Administration / Critical Path Institute / Imaging biomarker / Medicine / Biology / Clinical research


      FOR  IMMEDIATE  RELEASE    
Add to Reading List

Document Date: 2014-10-21 12:55:41

Open Document

File Size: 223,11 KB

Share Result on Facebook

City

TUCSON / /

Company

Ingelheim Pharmaceuticals Inc. / /

/

Facility

Critical Path Institute / Critical Path Institute The Critical Path Institute / /

IndustryTerm

pharmaceutical / /

MedicalCondition

proximal renal tubule degeneration/necrosis / /

Organization

U.S. Food and Drug Administration / /

/

Position

president and chief executive officer / head of translational safety / director / international leader / /

ProvinceOrState

Arizona / /

Technology

drug development / /

URL

www.c- / /

SocialTag